Immediate Impact
3 from Science/Nature 73 standout
Citing Papers
GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Works of K. Surrey being referenced
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
2004 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| K. Surrey | 1080 | 797 | 637 | 9 | 1.1k | |
| K.M. Beeh | 822 | 644 | 420 | 10 | 868 | |
| Stephen T. Holgate | 1009 | 671 | 323 | 9 | 1.2k | |
| T.F. Reiss | 909 | 761 | 317 | 10 | 1000 | |
| Fiona Nelson | 1042 | 776 | 278 | 8 | 1.2k | |
| Marijke Amelink | 1103 | 880 | 227 | 13 | 1.2k | |
| Gun Almqvist | 721 | 419 | 247 | 16 | 879 | |
| Sandhia Ponnarambil | 1241 | 858 | 339 | 14 | 1.4k | |
| Philippe Godard | 724 | 683 | 146 | 12 | 889 | |
| R P Young | 687 | 344 | 390 | 17 | 1.3k | |
| Julie Olsson | 576 | 582 | 208 | 13 | 1.1k |
All Works
Loading papers...